Note: Ingredients listed on restricted chemical lists
EC/CAS
204-355-4/119-90-4
Name of the chemical
3,3-dimethoxylbenzidine
Concentration
612-036-
General Information
Version
6.9
Revision date
2024-11-08
Product name
o-Dianisidine
CAS No.
119-90-4
REACH No
A
Emergency telephone
+420 228880039, +420 22491929...
Icons in SDS
Company Information
company name
Merck Life Science spol. s r. o
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H350
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Carcinogenicity, (Category 1B) H350: May cause cancer. Acute toxicity, (Category 4) H302: Harmful if swallowed.
Signal word
Danger Danger
Hazard statements
H302 Harmful if swallowed. H350 May cause cancer. H350 May cause cancer.
Precautionary statements
P201 Obtain special instructions before use. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Restricted to professional users. Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
